Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: Results of the German prospective randomized trial HIT '91

International Journal of Radiation Oncology Biology Physics

Volumn 46, Issue 2, 2000, Pages 269-279

  Kortmann, Rolf D ^a   Kühl, Joachim ^c   Timmermann, Beate ^a   Mittler, Uwe ^d   Urban, Christian ^e   Budach, Volker ^f   Richter, Eckart ^g   Willich, Normann ^h   Flentje, Michael ^c   Berthold, Frank ⁱ   Slavc, Irene ^j   Wolff, Johannes ^k   Meisner, Christoph ^b   Wiestler, Otmar ^l   Sörensen, Nils ^c   Warmuth Metz, Monika ^c   Bamberg, Michael ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e UNIVERSITY OF GRAZ   (Austria)

^f HUMBOLDT UNIVERSITY   (Germany)

^g UNIVERSITY OF LÜBECK   (Germany)

^h UNIVERSITY OF MÜNSTER   (Germany)

ⁱ UNIVERSITY OF COLOGNE   (Germany)

^j UNIVERSITY OF VIENNA   (Austria)

^k UNIVERSITY OF CALGARY   (Canada)

^l UNIVERSITY OF BONN   (Germany)

more..

Author keywords

Chemotherapy; Medulloblastoma; Quality assurance; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYTARABINE; ETOPOSIDE; FOLINATE CALCIUM; IFOSFAMIDE; LOMUSTINE; MESNA; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ARTICLE; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; NEUROPATHY; OTOTOXICITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT PLANNING;

ADOLESCENT; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW CELLS; CEREBELLAR NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; GERMANY; HUMANS; MALE; MEDULLOBLASTOMA; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 0342614892     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00369-7     Document Type: Article

References (35)

1. Bailey C.C., Gnekow A., Wellek S., Jones M., Round C., Brown J., Phillips A., Neidhardt M.K. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Pediatric Oncology (SIOP) and the (German) Society of Pediatric Oncology (GPO) SIOP II . Med Ped Oncol. 25:1995;166-178.
2. Evans A.E., Jenkin R.D.T., Sposto R., Ortega J.A., Wilson C.B., Wara W., Ertel I.J., Kramer S., Chang C.H., Leikin S.L., Hammond G.D. The treatment of medulloblastoma Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine and prednisone . J Neurosurg. 72:1990;572-582.
3. Tait D.M., Thornton-Jones H., Bloom H.J.G. Adjuvant chemotherapy for medulloblastoma The first multi-centre control trial of the International Society of Pediatric Oncology (SIOP I) . Eur J Cancer. 26:1990;464-469.
4. Packer R.J., Sutton L.N., Elterman R., Lange B., Goldwein J., Nicholson H.S., Mulne L., Boyett J., D'Angio G., Wechsler Jentzsch K., et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg. 81:1994;690-698.
5. Kühl J., Müller H.L., Kortmann R.D., Deinlein F., Maa E., Graf N., Gnekow A., Scheurlen W., Göbel U., Wolff J.E.A., Bamberg M., Kaatsch P., Kleihues P., Rating D., Wiestler O.D.T. Preirradiation chemotherapy of children and young adults with malignant brain tumours Results of the German pilot trial HIT'88/'89 . Klin Pädiatr. 210:1998;227-233.
6. Bleyer WA. Neurologic sequelae of methotrexate and ionizing radiation: A new classification. Cancer Treat Rep 1981;(Suppl. 1)65:89-98.
7. Bleyer WA. Chemoradiotherapy interactions in the central nervous system. Med Pediatr Oncol 1998;(Suppl. 1):10-16.
8. Cohen B.H., Zweidler P., Goldwein J.W., Molloy J., Packer R.J. Ototoxic effect of cisplatin in children with brain tumors. Pediatr Neurosurg. 16:1990;292-296.
9. Carrie C., Alapetite C., Mere P., Aimard L. Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study The contribution of radiotherapy technique to tumour relapse. The French Medulloblastoma Group . Radiother Oncol. 24:1992;77-81.
10. Grabenbauer G.G., Beck J.D., Erhardt J., Seegenschmidt M.H., Seyer H., Thierauf P., Sauer R. Postoperative radiotherapy of medulloblastoma Impact of radiation quality on treatment outcome . Am J Clin Oncol. 19:1996;73-77.
11. Miralbell R., Bleher A., Huguenin P., Ries G., Kann R., Mirimanoff R.O., Notter M., Nouet P., Bieri S., Thum P., Toussi H. Pediatric medulloblastoma Radiation treatment technique and patterns of failure . Int J Radiat Oncol Biol Phys. 37:1997;523-529.
12. Kleihues P., Burger P.C., Scheithauer B.W. The new WHO classification of brain tumours. Brain Pathol. 3:1993;255-268.
13. Levin V.A., Rodriguez L.A., Edwards M.S., Wara W., Liu H.C., Fulton D., Davis R.L., Wilson C.B., Silver P. Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine. J Neurosurg. 68:1988;383-387.
14. Mosijczuk A.D., Nigro M.A., Thomas P.R.M., Burger P.C., Krischer J.P., Morantz R.A., Kurdunowicz B., Mulne A.F., Towbin R.B., Freeman A.I., Nigro E.D., Friedman H.S., Kun L.E. Preradiation chemotherapy in advanced medulloblastoma. Cancer. 72:1993;2755-2762.
15. Neidhardt M., Bailey C.C., Gnekow A., Kleihues P., Michaelis J., Wellek S. [Medulloblastoma therapy studies MBL 80 and MED 84 of the Society of Pediatric Oncology and the Société Internationale d'Oncologie Pediatrique (SIOP)]. Klin Padiatr. 199:1987;188-192.
16. Packer R.J., Sutton L.N., Goldwein J.W., Perilongo G., Bunin G., Ryan J., Cohen B.H., D'Angio G., Kramer E.D., Zimmerman R.A., et al. Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg. 74:1991;433-440.
17. Choux M., Lena G., Hassoun J. Prognosis and long-term follow-up in patients with medulloblastoma. Clin Neurosurg. 30:1983;246-277.
18. David K.M., Casey A.T., Hayward R.D., Harkness W.F., Phipps K., Wade A.M. Medulloblastoma Is the 5-year survival rate improving? A review of 80 cases from a single institution . J Neurosurg. 86:1997;13-21.
19. Roberts R.O., Lynch C.F., Jones M.P., Hart M.N. Medulloblastoma A population-based study of 532 cases . J Neuropathol Exp Neurol. 50:1991;134-144.
20. Al Mefty O., Jinkins J.R., el Senoussi M., el Shaker M., Fox J.L. Medulloblastomas A review of modern management with a report on 75 cases . Surg Neurol. 24:1985;606-624.
21. Farwell J.R., Dohrmann G.J., Flannery J.T. Medulloblastoma in childhood An epidemiological study . J Neurosurg. 61:1984;657-664.
22. Gentet J.C., Bouffet E., Doz F., Tron P., Roche H., Thyss A., Plantaz D., Stephan J.L., Mottolese C., Ponvert D., Carrie C., Raybaud C., Brunat-Mentigny M., Choux M., Philip T., Zucker J.M., Bernard J.L. Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high dose methotrexate in childhood medulloblastoma Results of the M7 French cooperative study . J Neurosurg. 82:1995;608-614.
23. Jefferies S., Rajan B., Ashley S., Traish D., Brada M. Haematological toxicity of cranio-spinal irradiation. Radiother Oncol. 48:1998;23-27.
24. Röttinger E.M., Bailey C.C., Bamberg M. Treatment of medulloblastoma Dependence of outcome on quality of radiotherapy . Radiother Oncol. 32:1994;138.
25. Berry M.P., Jenkin R.D., Keen C.W., Nair B.D., Simpson W.J. Radiation treatment for medulloblastoma A 21-year review . J Neurosurg. 55:1981;43-51.
26. Hughes E.N., Shillito J., Sallan S.E., Loeffler J.S., Cassady J.R., Tarbell N.J. Medulloblastoma The Joint Centre for Radiation Therapy between 1968 and 1984: The influence of radiation dose on the pattern of failure and survival . Cancer. 61:1988;1992-1998.
27. Deutsch M., Thomas P.R., Krischer J., Boyett J.M., Albright L., Aronin P., Langston J., Allen J.C., Packer R.J., Linggood R., Mulhern R., Stanley P., Stehbens J.A., Duffner P., Kun L., Rorke L., Cherlow J., Freidman H., Finlay J.L., Vietti T. Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma A Combined Children's Cancer Group-Pediatric Oncology Group Study . Pediatr Neurosurg. 24:1996;167-176.
28. Tarbell N.J., Loeffler J.S., Silver B., Lynch E., Lavally B.L., Kupsky W.J., Scott R.M., Sallan S.E. The change in patterns of relapse in medulloblastoma. Cancer. 68:1991;1600-1604.
29. Pendergrass T.W., Milstein J.M., Geyer J.R., Mulne A.F., Kosnik E.J., Morris J.D., Heideman R.L., Ruymann F.B., Stuntz J.T., Bleyer W.A. Eight drugs in one day chemotherapy for brain tumors Experience in 107 children and rationale for preradiation chemotherapy . J Clin Oncol. 5:1987;1221-1231.
30. delCharco J.O., Bolek T.W., McCollough W.M., Maria B.L., Kedar A., Braylan R.C., Mickle J.P., Buatti J.M., Mendenhall N.P., Marcus R.B. Medulloblastoma Time-dose relationship based on a 30-year review . Int J Radiat Oncol Biol Phys. 42:1998;147-154.
31. Pezzota S., Cordero di Montezemolo L., Knerich R., Arrigoni M., Barbara A., Besenzon L., Brach del Prever A., Fidani P., Locatelli D., Loiancono G., Magrassi L., Perilongo G., Rigobello L., Urgesi A., Madon E. CNS-85 trial A cooperative pediatric CNS tumor study. Results of treatment of medulloblastoma patients . Child's Nerv Syst. 12:1996;87-96.
32. Zeltzer P.M., Boyett J.M., Finlay J.L., Albright A.L., Rorke L.B., Milstein J.M., Allen J.C., Stevens K.R., Stanley P., Li H., Wisoff J.H., Geyer J.R., McGuire Cullen P., Stehbens J.A., Shurin S.B., Packer R.J. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children Conclusions from the Children's Cancer Group 921 randomized phase III study . J Clin Oncol. 17:1999;832-845.
33. Prados M.D., Wara W., Edwards M.S., Ater J., Rabbit J., Lamborn K., Davis R., Levin V.A. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy. Pediatr Neurosurg. 25:1996;174-181.
34. Bouffet E., Gentet J.C., Doz F., Tron P., Roche H., Plantaz D., Thyss A., Stephan J.L., Lasset C., Carrie C., et al. Metastatic medulloblastoma The experience of the French Cooperative M7 Group . Eur J Cancer. 30A:1994;1478-1483.
35. Weil M.D., Lamborn K., Edwards M.S.B., Wara W.M. Influence of a child's sex on medulloblastoma outcome. JAMA. 279:1998;1474-1476.